Análise da eficácia do uso de cloridrato de Lurasidona no tratamento da Esquizofrenia em adultos-Reference-Cited by-同舟云学术

Análise da eficácia do uso de cloridrato de Lurasidona no tratamento da Esquizofrenia em adultos

Published:2024-01-12 Issue:2 Edição Especial Volume:16 Page:
ISSN:1989-4155
Container-title:Cuadernos de Educación y Desarrollo
language:
Short-container-title:Cuad. Ed. Desar.

Author:

Eich Nathany Martello,Cavalcante Mirian Lopes,Pereira Daiani Alves,Menezes Tiffany Santos,Lima José Virgulino de Oliveira

Abstract

O cloridrato de lurasidona é um antipsicótico de 2ª geração, aprovado em 2022 pela Agência Nacional de Vigilância Sanitária, no Brasil, como novo tratamento de esquizofrenia e transtorno bipolar.

Publisher

South Florida Publishing LLC

Reference5 articles.

1. ALLEN, Michael H et al. Efficacy of lurasidone in the treatment of agitation: A post hoc analysis of five short-term studies in acutely ill patients with schizophrenia. General hospital psychiatry, New York: Elsevier/North-Holland, vol. 47, 75-82, maio, 2017.

2. CALISTI, Fabrizio et al. Efficacy and safety of lurasidone in schizophrenia: pooled analysis of European results from double-blind, placebo-controlled 6-week studies. International clinical psychopharmacology, London: Clinical Neuroscience Publishers, vol. 37,5, 215-222, setembro, 2022.

3. LOEBEL, Antony et al. Treatment of early non-response in patients with schizophrenia: assessing the efficacy of antipsychotic dose escalation. BMC psychiatry, London: BioMed Central, v. 15, p. 1-7, outubro, 2015.

4. NASRALLA, Henry A et al. Lurasidone for the treatment of acutely psychotic patients with schizophrenia: a 6-week, randomized, placebo-controlled study. Journal of psychiatric research, Oxford: Pergamon Press., vol. 47,5, 670-7, maio, 2013.

5. STAHL, Stephen M et al. Effectiveness of lurasidone for patients with schizophrenia following 6 weeks of acute treatment with lurasidone, olanzapine, or placebo: a 6-month, open-label, extension study. The Journal of clinical psychiatry, Memphis, Tenn: Physicians Postgraduate Press., vol. 74,5, 507-15, maio, 2013.